Myeongmun Pharmaceutical ranked among the top searched stocks for 5 days within the past month.


As of 1:31 PM on the 28th, Myeongmun Pharmaceutical is trading at 7,020 KRW, down 5.9% from the previous day. This represents a 26.03% decrease compared to December 22. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

Today, foreigners have a provisional net purchase of 88,000 shares of Myeongmun Pharmaceutical, and institutions have a net purchase of 1,000 shares. Over the past 5 days, individual investors have net sold 31,285 shares, while foreigners and institutions have net bought 98,821 shares and net sold 978 shares, respectively.


On December 22, Myeongmun Pharmaceutical was a market topic for its rise following news of the sale of 'Camostat' to suppress COVID-19.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing